Toward improving synthetic efficiency, organic chemists have turned to
bioinspired organocascade or domino processes that generate multiple bonds and
stereocenters in a single operation. However, despite the great importance of
substituted cyclopentanes, given their prevalence in complex natural products
and pharmaceutical agents, the rapid, enantioselective assembly of these
carbocycles lags behind cyclohexanes. Herein, we describe a novel
Michael-aldol-β-lactonization organocascade process for the synthesis of
complex cyclopentanes utilizing chiral α,β-unsaturated
acylammonium intermediates, readily generated by activation of commodity
unsaturated acid chlorides with chiral isothiourea catalysts. This efficient
methodology enables the construction of two C-C bonds, one C-O bond, two rings,
and three contiguous stereogenic centers delivering complex cyclopentanes with
high levels of relative and absolute stereocontrol. Our results suggest that
unsaturated acyl ammonium intermediates have broad utility for the design of
organocascade and multicomponent processes with the latter demonstrated by a
Michael-Michael-aldol-β-lactonization.
An improved, tandem acid activation/aldol-lactonization process is described. This more practical protocol shortens reaction times for the construction of bicyclic β-lactones from ketoacids and implements the use of commercially available reagents p-toluenesulfonyl chloride (p-TsCl) as activator and 4-dimethylaminopyridine (4-DMAP) as nucleophilic promoter (Lewis base). Substrates with β-substituents, with respect to the carboxylic acid, consistently showed excellent levels of diastereoselectivity during the bis-cyclization event.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.